Jazz Pharmaceuticals (JAZZ) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Jazz Pharmaceuticals

    NASDAQ: JAZZ · Real-Time Price · USD
    139.48
    2.27 (1.65%)
    At close: Oct 03, 2025, 3:59 PM
    139.48
    0.00%
    After-hours: Oct 03, 2025, 04:38 PM EDT

    Jazz Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 2.41B 1.51B 881.48M 591.45M
    Short-Term Investments
    		 580M 120M n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 123.97M 73.94M 64.39M 52.84M
    Receivables
    		 716.76M 705.79M 651.49M 563.36M
    Inventory
    		 480.44M 597.04M 714.06M 1.07B
    Other Current Assets
    		 261.54M 320.81M 267.19M 252.39M
    Total Current Assets
    		 4.63B 3.44B 2.61B 2.61B
    Property-Plant & Equipment
    		 227M 234.99M 301.38M 343.42M
    Goodwill & Intangibles
    		 6.47B 7.17B 7.49B 8.98B
    Total Long-Term Assets
    		 7.38B 7.96B 8.23B 9.69B
    Total Assets
    		 12.01B 11.39B 10.84B 12.3B
    Account Payables
    		 77.87M 102.75M 90.76M 100.3M
    Deferred Revenue
    		 n/a n/a 463K 2.09M
    Short-Term Debt
    		 31M 604.95M 31M 31M
    Other Current Liabilities
    		 189.76M 142.32M 169.41M 193.1M
    Total Current Liabilities
    		 1.04B 1.54B 933.19M 809.3M
    Long-Term Debt
    		 6.08B 5.11B 5.69B 6.02B
    Other Long-Term Liabilities
    		 86.61M 104.75M 106.81M 117M
    Total Long-Term Liabilities
    		 6.88B 6.12B 6.82B 7.52B
    Total Liabilities
    		 7.92B 7.66B 7.75B 8.33B
    Total Debt
    		 6.16B 5.79B 5.81B 6.15B
    Book Value
    		 4.09B 3.74B 3.09B 3.97B
    Book Value Per Share
    		 66.20 59.04 49.34 66.43
    Common Stock
    		 61K 61K 61K 61K
    Retained Earnings
    		 1.13B 878.66M 733.59M 830.23M
    Comprehensive Income
    		 -947.67M -842.15M -1.13B -400.36M
    Shareholders Equity
    		 4.09B 3.74B 3.09B 3.97B
    Total Investments
    		 580M 120M n/a n/a

    Add to Watchlist